---
document_datetime: 2025-12-02 05:06:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/urorec.html
document_name: urorec.html
version: success
processing_time: 0.124478
conversion_datetime: 2025-12-26 12:19:54.817889
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Urorec

[RSS](/en/individual-human-medicine.xml/67062)

##### Authorised

This medicine is authorised for use in the European Union

silodosin Medicine Human Authorised

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [Product information - with tracked changes](#product-information-with-tracked-changes-76296)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine.

If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis for the CHMP recommendations, read the scientific discussion (also part of the EPAR).

Expand section

Collapse section

## What is Urorec?

Urorec is a medicine that contains the active substance silodosin. It is available as capsules (yellow: 4 mg; white: 8 mg).

## What is Urorec used for?

Urorec is used to treat the symptoms of benign prostatic hyperplasia (BPH, an enlarged prostate gland). The prostate gland is an organ found at the base of the bladder in men. When enlarged, it can cause problems with the flow of urine.

The medicine can only be obtained with a prescription.

## How is Urorec used?

The recommended dose is one 8-mg capsule once a day. For men with moderate kidney problems, the starting dose should be 4 mg once a day. This may be increased to 8 mg once a day after a week.

Urorec is not recommended for patients with severe kidney problems.

The capsules should be taken with food, preferably at the same time every day. They should be swallowed whole, preferably with a glass of water.

## How does Urorec work?

The active substance in Urorec, silodosin, is an alpha-adrenoreceptor antagonist. It works by blocking receptors called alpha1A adrenoreceptors in the prostate gland, the bladder and the urethra (the tube that leads from the bladder to the outside of the body). When these receptors are activated, they cause the muscles controlling the flow of urine to contract. By blocking these receptors, silodosin allows these muscles to relax, making it easier to pass urine and relieving the symptoms of BPH.

## How has Urorec been studied?

The effects of Urorec were first tested in experimental models before being studied in humans. Urorec has been compared with placebo (a dummy treatment) in three main studies involving over 1,800 men with BPH. One of these studies also compared Urorec with tamsulosin (another medicine used for BPH).

The main measure of effectiveness in all three studies was the improvement of the patients' international prostate symptom score (IPSS) after 12 weeks of treatment. IPSS is a rating of the patient's symptoms such as the inability to empty the bladder, and the urge to urinate repeatedly or to strain while urinating. The patients rated the severity of their symptoms themselves.

## What benefit has Urorec shown during the studies?

Urorec was more effective than placebo and as effective as tamsulosin at reducing symptoms of BPH.

In the two studies where Urorec was compared only with placebo, the IPSS was around 21 points at the start of the study. After 12 weeks, it had fallen by around 6.4 points in the men who took Urorec, and by around 3.5 points in the men who took placebo. In the third study, IPSS was around 19 points before treatment, falling by 7.0 points in the men who took Urorec after 12 weeks, 6.7 points in the men who took tamsulosin and 4.7 points in the men who took placebo.

## What is the risk associated with Urorec?

The most common side effect with Urorec (seen in more than 1 patient in 10) is a reduction in the amount of semen released during ejaculation. For the full list of all side effects reported with Urorec, see the package leaflet.

Urorec should not be used in people who may be hypersensitive (allergic) to silodosin or any of the other ingredients.

Intra-operative floppy iris syndrome (IFIS) occurs in some patients taking alpha-adrenoreceptor antagonists and may lead to complications during cataract surgery. IFIS is a condition that makes the iris floppy.

## Why has Urorec been approved?

The Committee for Medicinal Products for Human Use (CHMP) decided that Urorec's benefits are greater than its risks and recommended that it be given marketing authorisation.

## What measures are being taken to ensure the safe use of Urorec?

The company that makes Urorec will ensure that eye surgeons are provided with information on IFIS in all Member States where the medicine will be marketed.

## Other information about Urorec

The European Commission granted a marketing authorisation valid throughout the European Union for Urorec to Recordati Ireland Ltd. on 29 January 2010. The marketing authorisation is valid for five years, after which it can be renewed.

Urorec : EPAR - Summary for the public

English (EN) (73.61 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 08/10/2014

[View](/en/documents/overview/urorec-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-707)

български (BG) (102.7 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/bg/documents/overview/urorec-epar-summary-public_bg.pdf)

español (ES) (96.59 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/es/documents/overview/urorec-epar-summary-public_es.pdf)

čeština (CS) (123.54 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/cs/documents/overview/urorec-epar-summary-public_cs.pdf)

dansk (DA) (103.29 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/da/documents/overview/urorec-epar-summary-public_da.pdf)

Deutsch (DE) (75.29 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/de/documents/overview/urorec-epar-summary-public_de.pdf)

eesti keel (ET) (73.63 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/et/documents/overview/urorec-epar-summary-public_et.pdf)

ελληνικά (EL) (99.91 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/el/documents/overview/urorec-epar-summary-public_el.pdf)

français (FR) (74.85 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/fr/documents/overview/urorec-epar-summary-public_fr.pdf)

hrvatski (HR) (94.43 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/hr/documents/overview/urorec-epar-summary-public_hr.pdf)

italiano (IT) (73.52 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/it/documents/overview/urorec-epar-summary-public_it.pdf)

latviešu valoda (LV) (118.51 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/lv/documents/overview/urorec-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (97.93 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/lt/documents/overview/urorec-epar-summary-public_lt.pdf)

magyar (HU) (94.11 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/hu/documents/overview/urorec-epar-summary-public_hu.pdf)

Malti (MT) (101.21 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/mt/documents/overview/urorec-epar-summary-public_mt.pdf)

Nederlands (NL) (74.94 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/nl/documents/overview/urorec-epar-summary-public_nl.pdf)

polski (PL) (101.56 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/pl/documents/overview/urorec-epar-summary-public_pl.pdf)

português (PT) (74.98 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/pt/documents/overview/urorec-epar-summary-public_pt.pdf)

română (RO) (95.85 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/ro/documents/overview/urorec-epar-summary-public_ro.pdf)

slovenčina (SK) (121.36 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/sk/documents/overview/urorec-epar-summary-public_sk.pdf)

slovenščina (SL) (117.11 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/sl/documents/overview/urorec-epar-summary-public_sl.pdf)

Suomi (FI) (73.84 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/fi/documents/overview/urorec-epar-summary-public_fi.pdf)

svenska (SV) (74.11 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

08/10/2014

[View](/sv/documents/overview/urorec-epar-summary-public_sv.pdf)

## Product information

Urorec : EPAR - Product Information

English (EN) (380.73 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 07/05/2025

[View](/en/documents/product-information/urorec-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-732)

български (BG) (444.63 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/bg/documents/product-information/urorec-epar-product-information_bg.pdf)

español (ES) (377.47 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/es/documents/product-information/urorec-epar-product-information_es.pdf)

čeština (CS) (434.22 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/cs/documents/product-information/urorec-epar-product-information_cs.pdf)

dansk (DA) (381.9 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/da/documents/product-information/urorec-epar-product-information_da.pdf)

Deutsch (DE) (389.55 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/de/documents/product-information/urorec-epar-product-information_de.pdf)

eesti keel (ET) (390.71 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/et/documents/product-information/urorec-epar-product-information_et.pdf)

ελληνικά (EL) (457.77 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/el/documents/product-information/urorec-epar-product-information_el.pdf)

français (FR) (382.39 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/fr/documents/product-information/urorec-epar-product-information_fr.pdf)

hrvatski (HR) (417.15 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/hr/documents/product-information/urorec-epar-product-information_hr.pdf)

íslenska (IS) (376.1 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/is/documents/product-information/urorec-epar-product-information_is.pdf)

italiano (IT) (377.73 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/it/documents/product-information/urorec-epar-product-information_it.pdf)

latviešu valoda (LV) (440.28 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/lv/documents/product-information/urorec-epar-product-information_lv.pdf)

lietuvių kalba (LT) (437.94 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/lt/documents/product-information/urorec-epar-product-information_lt.pdf)

magyar (HU) (438.91 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/hu/documents/product-information/urorec-epar-product-information_hu.pdf)

Malti (MT) (484.72 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/mt/documents/product-information/urorec-epar-product-information_mt.pdf)

Nederlands (NL) (391.35 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/nl/documents/product-information/urorec-epar-product-information_nl.pdf)

norsk (NO) (405.17 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/no/documents/product-information/urorec-epar-product-information_no.pdf)

polski (PL) (443.71 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/pl/documents/product-information/urorec-epar-product-information_pl.pdf)

português (PT) (378.97 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/pt/documents/product-information/urorec-epar-product-information_pt.pdf)

română (RO) (441.58 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/ro/documents/product-information/urorec-epar-product-information_ro.pdf)

slovenčina (SK) (491.76 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/sk/documents/product-information/urorec-epar-product-information_sk.pdf)

slovenščina (SL) (432.63 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/sl/documents/product-information/urorec-epar-product-information_sl.pdf)

Suomi (FI) (378.18 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/fi/documents/product-information/urorec-epar-product-information_fi.pdf)

svenska (SV) (360.46 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

07/05/2025

[View](/sv/documents/product-information/urorec-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0000268274 06/05/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Urorec : EPAR - All Authorised presentations

English (EN) (12.61 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 22/02/2010

[View](/en/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_en.pdf)

[Other languages (23)](#file-language-dropdown-824)

български (BG) (82.66 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/bg/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_bg.pdf)

español (ES) (13.42 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/es/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_es.pdf)

čeština (CS) (31.44 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/cs/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (15.7 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/da/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (15.68 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/de/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (15.8 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/et/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (78.11 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/el/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_el.pdf)

français (FR) (16.13 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/fr/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_fr.pdf)

íslenska (IS) (23 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/is/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_is.pdf)

italiano (IT) (15.15 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/it/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (82.37 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/lv/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (83.23 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/lt/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (45.95 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/hu/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (80.93 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/mt/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (15.71 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/nl/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (21.63 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/no/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_no.pdf)

polski (PL) (83.66 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/pl/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_pl.pdf)

português (PT) (13.51 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/pt/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_pt.pdf)

română (RO) (79.23 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/ro/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (45.73 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sk/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (15.49 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sl/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (16.2 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/fi/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (15.99 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sv/documents/all-authorised-presentations/urorec-epar-all-authorised-presentations_sv.pdf)

Urorec : EPAR - Conditions imposed on member states for safe and effective use - Annex IV

English (EN) (72.53 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 22/02/2010

[View](/en/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_en.pdf)

[Other languages (21)](#file-language-dropdown-809)

български (BG) (150.94 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/bg/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_bg.pdf)

español (ES) (67.65 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/es/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_es.pdf)

čeština (CS) (96.03 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/cs/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_cs.pdf)

dansk (DA) (60.92 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/da/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_da.pdf)

Deutsch (DE) (71.21 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/de/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_de.pdf)

eesti keel (ET) (62.22 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/et/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_et.pdf)

ελληνικά (EL) (148.5 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/el/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_el.pdf)

français (FR) (71.06 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/fr/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fr.pdf)

italiano (IT) (64.87 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/it/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_it.pdf)

latviešu valoda (LV) (99.2 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/lv/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lv.pdf)

lietuvių kalba (LT) (95.51 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/lt/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lt.pdf)

magyar (HU) (69.91 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/hu/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_hu.pdf)

Malti (MT) (109.73 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/mt/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_mt.pdf)

Nederlands (NL) (69.5 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/nl/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_nl.pdf)

polski (PL) (97.68 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/pl/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pl.pdf)

português (PT) (66.3 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/pt/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pt.pdf)

română (RO) (95.37 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/ro/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_ro.pdf)

slovenčina (SK) (149.8 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sk/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sk.pdf)

slovenščina (SL) (84.64 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sl/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sl.pdf)

Suomi (FI) (65.93 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/fi/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fi.pdf)

svenska (SV) (66.36 KB - PDF)

**First published:**

22/02/2010

**Last updated:**

22/02/2010

[View](/sv/documents/conditions-member-states/urorec-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sv.pdf)

## Product details

Name of medicine Urorec Active substance silodosin International non-proprietary name (INN) or common name silodosin Therapeutic area (MeSH) Prostatic Hyperplasia Anatomical therapeutic chemical (ATC) code G04CA04

### Pharmacotherapeutic group

Urologicals

### Therapeutic indication

Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

## Authorisation details

EMA product number EMEA/H/C/001092 Marketing authorisation holder

Recordati Ireland Ltd

Raheens East

Opinion adopted 19/11/2009 Marketing authorisation issued 29/01/2010 Revision 20

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Urorec : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (140.29 KB - PDF)

**First published:** 07/05/2025

[View](/en/documents/procedural-steps-after/urorec-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Urorec : EPAR - Procedural steps taken and scientific information after authorisation (archive)

English (EN) (184.72 KB - PDF)

**First published:** 22/06/2010

**Last updated:** 07/05/2025

[View](/en/documents/procedural-steps-after/urorec-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf)

Urorec-H-C-1092-PSUV-0013: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/704813/2013

English (EN) (69.67 KB - PDF)

**First published:** 22/11/2013

**Last updated:** 22/11/2013

[View](/en/documents/scientific-conclusion/urorec-h-c-1092-psuv-0013-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Urorec : EPAR - Public assessment report

English (EN) (620.29 KB - PDF)

**First published:** 22/02/2010

**Last updated:** 22/02/2010

[View](/en/documents/assessment-report/urorec-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Urorec

Adopted

Reference Number: EMEA/CHMP/597059/2009

English (EN) (74.59 KB - PDF)

**First published:** 19/11/2009

**Last updated:** 19/11/2009

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-urorec_en.pdf)

#### Product information - with tracked changes

The approved product information for this medicine is available below showing the changes since the previous procedure affecting the product information. The same document without tracked changes is above under 'Product information'.

Urorec : EPAR - Product information - tracked changes

English (EN) (225 KB - DOC)

**First published:** 07/05/2025

[View](/en/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_en.doc)

[Other languages (24)](#file-language-dropdown-998)

български (BG) (326.5 KB - DOC)

**First published:**

07/05/2025

[View](/bg/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_bg.doc)

español (ES) (279.5 KB - DOC)

**First published:**

07/05/2025

[View](/es/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_es.doc)

čeština (CS) (289 KB - DOC)

**First published:**

07/05/2025

[View](/cs/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_cs.doc)

dansk (DA) (280 KB - DOC)

**First published:**

07/05/2025

[View](/da/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_da.doc)

Deutsch (DE) (231.5 KB - DOC)

**First published:**

07/05/2025

[View](/de/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_de.doc)

eesti keel (ET) (243.5 KB - DOC)

**First published:**

07/05/2025

[View](/et/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_et.doc)

ελληνικά (EL) (305.5 KB - DOC)

**First published:**

07/05/2025

[View](/el/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_el.doc)

français (FR) (247.5 KB - DOC)

**First published:**

07/05/2025

[View](/fr/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_fr.doc)

hrvatski (HR) (315.5 KB - DOC)

**First published:**

07/05/2025

[View](/hr/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_hr.doc)

íslenska (IS) (228.5 KB - DOC)

**First published:**

07/05/2025

[View](/is/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_is.doc)

italiano (IT) (226 KB - DOC)

**First published:**

07/05/2025

[View](/it/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_it.doc)

latviešu valoda (LV) (353 KB - DOC)

**First published:**

07/05/2025

[View](/lv/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_lv.doc)

lietuvių kalba (LT) (316.5 KB - DOC)

**First published:**

07/05/2025

[View](/lt/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_lt.doc)

magyar (HU) (311 KB - DOC)

**First published:**

07/05/2025

[View](/hu/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_hu.doc)

Malti (MT) (362 KB - DOC)

**First published:**

07/05/2025

[View](/mt/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_mt.doc)

Nederlands (NL) (239.5 KB - DOC)

**First published:**

07/05/2025

[View](/nl/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_nl.doc)

norsk (NO) (236 KB - DOC)

**First published:**

07/05/2025

[View](/no/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_no.doc)

polski (PL) (282 KB - DOC)

**First published:**

07/05/2025

[View](/pl/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_pl.doc)

português (PT) (261.5 KB - DOC)

**First published:**

07/05/2025

[View](/pt/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_pt.doc)

română (RO) (341 KB - DOC)

**First published:**

07/05/2025

[View](/ro/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_ro.doc)

slovenčina (SK) (282.5 KB - DOC)

**First published:**

07/05/2025

[View](/sk/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_sk.doc)

slovenščina (SL) (273.5 KB - DOC)

**First published:**

07/05/2025

[View](/sl/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_sl.doc)

Suomi (FI) (232 KB - DOC)

**First published:**

07/05/2025

[View](/fi/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_fi.doc)

svenska (SV) (253 KB - DOC)

**First published:**

07/05/2025

[View](/sv/documents/product-information-tracked-changes/urorec-epar-product-information-tracked-changes_sv.doc)

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 07/05/2025

## Share this page

[Back to top](#main-content)